Transthyretin Y78F Variant Monomers

CAT:
400-SPR-452B
Size:
100 µg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: Yes
Transthyretin Y78F Variant Monomers - image 1
Transthyretin Y78F Variant Monomers - image 2
Thumbnail 1
Thumbnail 2

Transthyretin Y78F Variant Monomers

  • Background:

    Transthyretin is a transport protein in the serum and cerebospinal fluid that carried the thyroid hormone Thyroxine and retinol-binding protein bound to retinol. TTR misfolding and aggregation is known to be associated with the amyloiddiseases SSA, FAP and FAC (1-5). TTR is also thought to have beneficial side effects, such as binding to beta-amyloid protein, preventing beta-amyloid from accumulating into the plaques associated with Alzheimer's Disease (6). The mutant variant Y78F indicates a destabilization of the contacts between the alpha-helix and AB loop and the body of the molecule, potentially leading to applications in immne therapy for FAP (7).
  • Description:

    Human Recombinant Transthyretin Y78F Variant Protein Monomers
  • Product Name Alternative:

    Amyloid polyneuropathy Protein Monomer, Amyloidosis I Protein Monomer, ATTR Protein Monomer, Carpal tunnel syndrome 1 Protein Monomer, CTS Protein Monomer, CTS1 Protein Monomer,= HEL111 Protein Monomer, HsT2651 Protein Monomer, PALB Protein Monomer, Prealbumin Protein Monomer, Prealbumin amyloidosis type I Protein Monomer, Prealbumin Thyroxine-binding Protein Monomer, TBPA Protein Monomer, Thyroxine binding prealbumin Protein Monomer, Transthyretin Protein Monomer, TTHY_HUMAN Protein Monomer,TTR Protein Monomer, TTR protein
  • UNSPSC:

    12352202
  • Gene ID:

    7276
  • Swiss Prot:

    P02766
  • Accession Number:

    NP_000362.1
  • Cellular Locus:

    Cytoplasm | Extracellular exosome | Extracellular Region | Lysosome
  • Host:

    E. coli
  • Origin Species:

    Human
  • Target:

    Transthyretin (TTR)
  • Conjugation:

    No tag
  • Sequence:

    MGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSFWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE
  • Applications:

    WB, SDS-PAGE, In vivo assay, In vitro assay
  • Purification Method:

    Ion-exchange Purified
  • Concentration:

    Lot/batch specific. See included datasheet.
  • Purity:

    >95%
  • Weight:

    0
  • Length:

    Full length
  • Buffer:

    PBS pH 7.4
  • Molecular Weight:

    13.876 kDa
  • Precautions:

    Not for use in humans. Not for use in diagnostics or therapeutics. For research use only.
  • Additionnal Information:

    For corresponding PFFs, see catalog# SPR-465
  • References & Citations:

    1. Zeldenrust S.R., Benson M.D. (2010). Wiley. pp. 795–815. 2. Westermark P., Sletten K., Johansson B., Cornwell G.G. (1990). Proc. Natl. Acad. Sci. U.S.A. 87(7): 2843–5. 3. Andrade C. (1952). Brain. 75(3): 408–27. 4. Coelho T. (1996). Curr. Opin. Neurol. 9(5): 355–9. 5. Jacobson D.R, et. al. (1997). N. Engl. J. Med. 336(7): 466–73. 6. Li X. (2011). Mol Neurodegener. 6(1):79. 7. Terazaki H.,m et al. (2006) Lab Invest. 86(1): 23-31.

MSDS

MSDS Document

View Document